GB1210968A - Improvements in or relating to the treatment of gastric ailments - Google Patents

Improvements in or relating to the treatment of gastric ailments

Info

Publication number: GB1210968A
Authority: GB; United Kingdom
Prior art keywords: medicaments; treatment; lysine; oct; diamino acid
Prior art date: 1967-10-11
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

GB47768/68A

Other languages

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Far Eastern Detailers Ltd

Original Assignee

Far Eastern Detailers Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1967-10-11

Filing date

1968-10-09

Publication date

1970-11-04

1968-10-09 Application filed by Far Eastern Detailers Ltd filed Critical Far Eastern Detailers Ltd

1970-11-04 Publication of GB1210968A publication Critical patent/GB1210968A/en

Status Expired legal-status Critical Current

Links

230000002496 gastric effect Effects 0.000 title abstract 2
239000003814 drug Substances 0.000 abstract 4
239000004472 Lysine Substances 0.000 abstract 2
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 abstract 2
239000002253 acid Substances 0.000 abstract 2
239000004475 Arginine Substances 0.000 abstract 1
LCWXJXMHJVIJFK-UHFFFAOYSA-N Hydroxylysine Natural products NCC(O)CC(N)CC(O)=O LCWXJXMHJVIJFK-UHFFFAOYSA-N 0.000 abstract 1
206010020601 Hyperchlorhydria Diseases 0.000 abstract 1
AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 abstract 1
ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 abstract 1
KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 abstract 1
AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 abstract 1
UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 abstract 1
125000001931 aliphatic group Chemical group 0.000 abstract 1
239000012736 aqueous medium Substances 0.000 abstract 1
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 abstract 1
239000002775 capsule Substances 0.000 abstract 1
YSMODUONRAFBET-UHFFFAOYSA-N delta-DL-hydroxylysine Natural products NCC(O)CCC(N)C(O)=O YSMODUONRAFBET-UHFFFAOYSA-N 0.000 abstract 1
239000008298 dragée Substances 0.000 abstract 1
239000003937 drug carrier Substances 0.000 abstract 1
YSMODUONRAFBET-UHNVWZDZSA-N erythro-5-hydroxy-L-lysine Chemical compound NC[C@H](O)CC[C@H](N)C(O)=O YSMODUONRAFBET-UHNVWZDZSA-N 0.000 abstract 1
QYRFJLLXPINATB-UHFFFAOYSA-N hydron;2,4,5,6-tetrafluorobenzene-1,3-diamine;dichloride Chemical compound Cl.Cl.NC1=C(F)C(N)=C(F)C(F)=C1F QYRFJLLXPINATB-UHFFFAOYSA-N 0.000 abstract 1
QJHBJHUKURJDLG-UHFFFAOYSA-N hydroxy-L-lysine Natural products NCCCCC(NO)C(O)=O QJHBJHUKURJDLG-UHFFFAOYSA-N 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
229960003104 ornithine Drugs 0.000 abstract 1
239000000843 powder Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
210000002784 stomach Anatomy 0.000 abstract 1
235000020357 syrup Nutrition 0.000 abstract 1
239000006188 syrup Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Preparation (AREA)

GB47768/68A 1967-10-11 1968-10-09 Improvements in or relating to the treatment of gastric ailments Expired GB1210968A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR124017A FR6588M (de)	1967-10-11	1967-10-11

Publications (1)

Publication Number	Publication Date
GB1210968A true GB1210968A (en)	1970-11-04

Family

ID=8639882

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GB47768/68A Expired GB1210968A (en)	1967-10-11	1968-10-09	Improvements in or relating to the treatment of gastric ailments

Country Status (2)

Country	Link
FR (1)	FR6588M (de)
GB (1)	GB1210968A (de)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3438455A1 (de) *	1984-10-19	1986-06-26	Institut Dr. Ziegler, Bettingen	L-lysin- und l-histidinpyruvat
GB2209120A (en) *	1987-08-28	1989-05-04	Hoerrmann Wilhelm	Anti-tumour compositions containing lysine derivatives
GB2226759A (en) *	1987-12-30	1990-07-11	Wilhelm Hoerrmann	Pharmaceutical compositions containing lysine
WO2002094256A1 (en) *	2001-05-23	2002-11-28	Debatosh Datta	Lysine and/or analogues and/or polymers thereof for promoting wound healing and angiogenesis
EP1550443A1 (de) *	2002-09-18	2005-07-06	Ajinomoto Co., Inc.	Zusammensetzung gegen stressbedingte erkrankungen
JP2009167195A (ja) *	2001-03-23	2009-07-30	Ajinomoto Co Inc	抗ストレス性疾患剤

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1131854B (it) *	1980-06-30	1986-06-25	Baldacci Lab Spa	Composizione farmaceutica per uso terapeutico,per uso diagnostico e quale integratore alimentare

1967
- 1967-10-11 FR FR124017A patent/FR6588M/fr not_active Expired
1968
- 1968-10-09 GB GB47768/68A patent/GB1210968A/en not_active Expired

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3438455A1 (de) *	1984-10-19	1986-06-26	Institut Dr. Ziegler, Bettingen	L-lysin- und l-histidinpyruvat
GB2209120A (en) *	1987-08-28	1989-05-04	Hoerrmann Wilhelm	Anti-tumour compositions containing lysine derivatives
GB2209120B (en) *	1987-08-28	1992-01-15	Hoerrmann Wilhelm	Drugs containing lysine or hydroxylysine derivatives
GB2226759A (en) *	1987-12-30	1990-07-11	Wilhelm Hoerrmann	Pharmaceutical compositions containing lysine
JP2009167195A (ja) *	2001-03-23	2009-07-30	Ajinomoto Co Inc	抗ストレス性疾患剤
WO2002094256A1 (en) *	2001-05-23	2002-11-28	Debatosh Datta	Lysine and/or analogues and/or polymers thereof for promoting wound healing and angiogenesis
EP1550443A1 (de) *	2002-09-18	2005-07-06	Ajinomoto Co., Inc.	Zusammensetzung gegen stressbedingte erkrankungen
EP1550443A4 (de) *	2002-09-18	2009-04-01	Ajinomoto Kk	Zusammensetzung gegen stressbedingte erkrankungen

Also Published As

Publication number	Publication date
FR6588M (de)	1968-12-30

Similar Documents

Publication	Publication Date	Title
GB1221393A (en)	1971-02-03	Improvements in or relating to hepato-protective drugs
GB1388358A (en)	1975-03-26	Taste-improving formulations of oral penicillins
GB1210968A (en)	1970-11-04	Improvements in or relating to the treatment of gastric ailments
GB1487334A (en)	1977-09-28	Pharmaceutical preparations comprising lisuride and/or physiologically tolerable salts thereof
GB1191246A (en)	1970-05-13	Vitamin-containing Preparations
ES264510A1 (es)	1961-10-01	Metodo para la preparaciën de preparados de hierro de elevado poder de absorciën
GB1118606A (en)	1968-07-03	Compositions for the treatment of haemorrhoids
GB1184110A (en)	1970-03-11	Compositions for Treating Mental Disorders
GB1187873A (en)	1970-04-15	Pharmaceutical Compositions Comprising a Cardiac Glycoside.
GB1327469A (en)	1973-08-22	Pharmaceutical compositions for inhibiting indoleamine n-methyl transferase
GB1352392A (en)	1974-05-08	Phenylisopropylamine derivatives
GB1227646A (de)	1971-04-07
GB1356489A (en)	1974-06-12	Compositions for and method of combating coccidiosis and mareks disease in poultry
GB1246315A (en)	1971-09-15	Pharmaceutical compositions
GB1246727A (en)	1971-09-15	Therapeutic hypotensive compositions comprising 5-alkylpicolinic acids
GB1153014A (en)	1969-05-21	Improvements in or relating to An Oral Dose for the Treatment of Tuberculosis
GB1422745A (en)	1976-01-28	Pharmaceutical compositions containing 4-hydroxy- 1,23-benzotriazine and methods of using same
GB908634A (en)	1962-10-24	Pharmaceutical compositions containing pararosaniline or derivatives thereof
GB1386927A (en)	1975-03-12	Preparations for combatting swine dysentery
GB1167688A (en)	1969-10-22	Dealkylation of Cyclic N-alkyl Derivatives
GB1173985A (en)	1969-12-10	Indole Derivatives
GB1250279A (de)	1971-10-20
GB1251237A (de)	1971-10-27
Tallarida et al.	1982	Clinoril®(Merck Sharp & Dohme) Sulindac
GB1207745A (en)	1970-10-07	A tranquillizer-containing composition

Legal Events

Date	Code	Title	Description
1971-05-12	PS	Patent sealed [section 19, patents act 1949]
1984-06-13	PCNP	Patent ceased through non-payment of renewal fee